A significant player in the agricultural industry, Corteva (NYSE:CTVA) focuses on specialty chemicals and seeds. Clocking in at number 208 on the S&P 500 list, Corteva currently sports a market capitalization of just under $36 billion. Though a vital component of our national infrastructure, the market unfortunately has other ideas. Since the start of the year, CTVA slipped more than 15% in equity value.
With that kind of print, CTVA might not seem an ideal candidate for high-growth S&P 500 stocks to buy. However, as boring as the underlying agricultural sector is, geopolitics has made (regrettably) more exciting. With adversarial nations competing for access to precious resources, the U.S. must not lag behind. From a purely cynical perspective, Corteva holds much promise.
Also, it may offer enticing value for forward-looking investors. Currently, shares trade at 1.37x book value. In contrast, the sector median hits a loftier 1.66x. Analysts rate CTVA a strong buy with a $68.92 target, implying over 38% upside potential.
No comments:
Post a Comment